PharmaEssentia Corporation (TPE:6446)
1,205.00
-40.00 (-3.21%)
Nov 19, 2026, 1:30 PM CST
PharmaEssentia Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, PharmaEssentia stock has a consensus rating of "Buy" and an average price target of $1,481. The average 1-year stock price forecast is 22.93% higher than the current stock price, while the lowest is $500.33 (-58.48%) and the highest is $2,143 (+77.84%).
Price Target: $1,481 (+22.93%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaEssentia stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
28.05B
from 15.63B
Increased by 79.38%
Revenue Next Year
42.90B
from 28.05B
Increased by 52.95%
EPS This Year
25.86
from 12.25
Increased by 111.09%
EPS Next Year
44.11
from 25.86
Increased by 70.57%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.